India's Pharmaceutical Exports

Country Profile

South Sudan

South Sudan is a developing market for Indian pharmaceuticals — $6.68M in FY 2025–26, with 27.4× growth over the past decade. Medicines accounts for 93% of shipments, with vaccines contributing $171K. The compound annual growth rate since FY2017 stands at 44.5%.

🇸🇸 $6.68M · 27.4× growth since FY2017 · 44.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$6.68M
Exports FY2025–26 DGCIS
27.4×
Growth FY2017→2026
44.5%
CAGR FY2017→2026
93%
Medicines Share
3
Product Categories Supplied
South Sudan is a developing market for Indian pharmaceuticals — $6.68M in FY 2025–26, with 27.4× growth over the past decade. Medicines accounts for 93% of shipments, with vaccines contributing $171K. The compound annual growth rate since FY2017 stands at 44.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $6.18M (92.5%) Surgical & Hospital Supplies $327K (4.9%) Vaccines $171K (2.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to South Sudan in the RBI overseas direct investment dataset (2011–2026).